DNA topoisomerase I together with the other cellular DNA topoisomerases releases the torsional stress from DNA caused by processes such as replication, transcription and recombination. Despite the well-defined knowledge of its mechanism of action, DNA topoisomerase I in vivo activity has been only partially characterized. In fact the basic question concerning the capability of the enzyme to cleave and rejoin DNA wrapped around a histone octamer remains still unanswered. By studying both in vivo and in vitro the cleavage activity of DNA topoisomerase I in the presence of camptothecin on a repeated trinucleotide sequence, (TTA) 35 , lying in chromosome XIII of Saccharomyces cerevisiae, we can conclude that nucleosomes represent a physical barrier for the enzyme activity.
INTRODUCTION
DNA topology in eukaryotic nuclei is controlled by a specific class of proteins, DNA topoisomerases [1] . These enzymes are classified into two groups depending on their catalytic activity: type I enzymes change DNA topology by breaking and rejoining one DNA strand at a time, whereas type II enzymes act simultaneously on both strands. In eukaryotes, DNA topoisomerase IB reduces the torsional stress arising from basic DNA processes such as transcription, replication and recombination [2] . Although DNA topoisomerase I is involved in such important functions, the enzyme is not essential in Saccharomyces cerevisiae [3] .
Despite the well-known mechanisms of DNA topoisomerase I activity and the susceptibility to different inhibitors [4] , its accessibility to the DNA in vivo has been poorly investigated. To date, evidence regarding the in vivo DNA topoisomerase I cleavage activity only refers to nucleosome-free regions [5] [6] [7] and it is not known whether nucleosomes could represent a barrier for DNA topoisomerase I to access DNA. In fact it has been demonstrated that nucleosomal complexes interfere with the accessibility of transcription and replication factors on DNA [8, 9] . Recently, Roca and co-workers [10] have demonstrated that DNA topoisomerase II relaxes nucleosomal DNA much faster than DNA topoisomerase I. By analysing the relaxing activities on different nucleosomal substrates they suggested that, in vivo, DNA topoisomerase I more than DNA topoisomerase II, could be impeded by nucleosomal structures in cleaving and rejoining DNA [10] . Actually the DNA topoisomerase I cleavage reaction on in vivo sequences has not yet been studied on substrates containing or not nucleosomes. In order to answer this question, in the present study we have evaluated the DNA topoisomerase I cleavage activity on the natural (TTA) 35 repeated sequence, both in vitro and in vivo. This sequence contains structural features presumably favouring both the DNA topoisomerase I site-specific cleavage activity and nucleosome assembly. In fact, the TTA sequence has been shown to be intrinsically flexible [11] and the TA step is locally bent [12] . These two features (i.e. flexibility and local bending) and the previous observation that DNA topoisomerase I in vitro efficiently cleaves the bent TA step [13] rendered the (TTA) 35 repeat a good substrate by which to evaluate the capability of DNA topoisomerase I to cleave a specific sequence, possibly in the presence of nucleosomes. In addition, using a strain where the H4 synthesis is under the control of the GAL1 promoter [14] , we were able to study the DNA topoisomerase I activity on a sequence where the nucleosome organization is lost or maintained in glucose or galactose respectively. This approach allowed us to study, in vivo, the DNA topoisomerase I reaction on different chromatin arrangements.
EXPERIMENTAL

Strains, plasmids and culture medium
The strains used were W303-1a (Mata, ade 2-1, ura 3-1, his 3-11,15, 35 region, was PCR amplified and cloned into the EcoRI site of the yeast vector pADH426 [15] yielding the plasmid pFDFG1a.
Cells were grown in minimal YNB (yeast nitrogen base) [16] , supplemented with 2 % glucose or 2 % galactose when appropriate.
Enzymes and chemicals
Restriction enzymes, T4 polynucleotide kinase and MNase (micrococcal nuclease) were from Roche. Vent(exo − ) polymerase was from New England Biolabs. Zymolyase 100T was from Seikagaku. CPT (camptothecin) was from Sigma and radiochemicals were obtained from Amersham.
Chromatin analysis
MNase treatment was performed as described previously [17] . MNase (2 and 4 units) was added to different aliquots of spheroplast preparation and the samples were incubated at 25
• C for 20 min. The DNA was then deproteinized and ethanol precipitated. RNase treatment was also performed.
Low-resolution analysis
Indirect end-labelling analysis [18] was performed as follows: after treatment with the appropriate restriction enzymes, the samples were electrophoresized in 1.2 % agarose gels (1.75 V/cm), transferred on to nitrocellulose membrane, hybridized to the TTA probe and detected by autoradiography.
In vivo induction of CPT-dependent DNA topoisomerase I cleavage sites
Cells were treated for cleavage-site induction as previously described [7] . Three different aliquots were incubated with 50, 100 or 200 µM CPT for 2 min at room temperature (25 • C). The reaction was stopped with 1 % SDS containing 5 mM EDTA. The DNA was then deproteinized and ethanol precipitated. RNase treatment was also performed.
Oligonucleotide primers and probes
The oligonucleotide sequences used in the extension reactions were VEC, 5 -GGTATCGATAAGCTTGATATCG-3 and r3, 5 -CGCGTTTCCGTATTTTCCGC-3 . The oligonucleotide VEC lies at position − 449 from the PRE8 ATG of the cloned sequence containing the (TTA) 35 in pFDFG1a. The r3 oligonucleotide used lies at position − 267/−248 bp from the 35S RNA RIS (RNA initiation site) complex. 5 -End labelling using [γ -32 P]ATP and T4 polynucleotide kinase was performed according to [19] .
The probe TTA, annealing at positions + 436/+232 bp from the ATG of the PRE8 gene, was labelled by random priming.
Multiple-round primer extension and high-resolution analysis of in vivo MNase and DNA topoisomerase I cleavage sites Genomic DNA (1-2 µg) was reacted with Vent polymerase and end-labelled oligonucleotide as described previously [20] . The samples were cycled 25 times through the following steps: 95
• C for 5 min, 58
• C for 10 min and 76 • C for 3 min (conditions for oligonucleotide VEC). The extension products were phenol extracted, ethanol precipitated, dissolved in formamide buffer and analysed by 6 % denaturing PAGE.
In vitro DNA topoisomerase I cleavage sites
The reactions were performed as described previously [21] by reacting 1, 5 and 10 units of purified DNA topoisomerase I (from calf thymus) with 1-2 ng of end-labelled DNA. The reactions were carried out in 10 mM Tris/HCl (pH 8.0), 10 mM NaCl, 1 mM MgCl 2 and 100 µM CPT for 15 min at 37
• C. The DNA substrate for the cleavage reaction was EcoRI excised from pFDFG1a. After restriction digestion with XhoI/XbaI the fragment was 3 -labelled, purified and further digested with SmaI or HindIII in order to uniquely orient the labelling. 
RESULTS
We selected the trinucleotide repeat (TTA) 35 lying in the intergenic region of chromosome XIII of S. cerevisiae, between the RPM2 (RNase P mitochondrial 2) and PRE8 genes. This sequence, as reported above, contains the structural elements presumably suitable to be susceptible to DNA topoisomerase I site-specific activity and to assemble nucleosomes.
In vitro high-resolution analysis of DNA topoisomerase I cleavage sites on the (TTA) 35 repeat
The DNA tract in chromosome XIII containing the sequence (TTA) 35 was amplified by PCR with two oligonucleotides annealing at positions − 474 and + 755 relative to the PRE8 ATG. The resulting fragment was cloned into the yeast vector pADH426, yielding the pFDFG1a plasmid. The XhoI/XbaI fragment from pFDFG1a was 3 -labelled, purified and further digested with SmaI in order to uniquely orient the labelling and to study the DNA topoisomerase I cleavages with a nucleotide level of resolution. The fragment was reacted in vitro with increasing amounts of calf thymus DNA topoisomerase I (indicated by the triangle in Figure 1 ) in the presence of CPT; this drug inhibits the rejoining reaction of DNA topoisomerase I thus creating, in the presence of a denaturing agent, single-strand breaks and behaving like a single-strand nuclease. As shown in Figure 1 , DNA topoisomerase I strongly recognized the TTA repeats (indicated by arrows in Figure 1 ). The regularly repeated sequence was highly cleaved (from − 312 to − 216) and TTA repetitions in the flanking regions were also efficiently cleaved. The asterisks on Figure 1 indicate cleavage sites not occurring in a TTA sequence.
In vivo analysis of DNA topoisomerase I cleavage sites on the (TTA) 35 repeat
Given the results shown in Figure 1 we evaluated the DNA topoisomerase I cleavage activity on the same DNA sequence in vivo. Wild-type and AMR51 ( top1) cells, transformed with pFDFG1a, were analysed for cleavage-site induction as previously reported [7, 20] . Briefly, spheroplasts from wild-type and top1 cells were permeabilized with nystatin [17] and treated with different amounts of CPT (indicated by the triangle in Figure 2 ). DNA was then purified and primer-extended from the labelled oligonucleotide VEC (annealing on the vector sequence at − 449 bp from the PRE8 ATG contained in the fragment cloned in pADH426). Only a weak cleavage profile was observed in the wild-type strain (Figure 2) . The only detectable sites were localized at the flanking regions of the triplet (indicated by arrows in Figure 2 ). In the top1 strain no cleavage sites were observed. Taken together, these results suggest that DNA topoisomerase I poorly reacts in vivo with the (TTA) 35 repeat despite its in vitro high reactivity towards the same sequence (Figure 1 ).
The (TTA) 35 repeat is engaged in a positioned nucleosome in vivo
Results shown in Figure 2 indicate that DNA topoisomerase I does not efficiently react with the (TTA) 35 tract in vivo. Could this low cleavage activity on the repeated sequence be due to its chromatin organization? In order to clarify this point we studied the nucleosome positioning on this DNA sequence by in vivo analysis with MNase.
Spheroplasts from wild-type cells, transformed with pFDFG1a, were treated with nystatin, digested with different amounts of MNase (indicated by the triangles in Figure 3 ) and DNA was purified. Results are shown in Figure 3(A) . The in vivo treated samples (chromatin) were compared with those digested in vitro (naked DNA) to indicate the susceptibility of deproteinized DNA to MNase. This comparison showed protected regions representing nucleosomal particles based on their dimension (140-160 bp) (indicated as ellipses in Figure 3 ). The nucleosome reported as #1 occupied positions from − 160 bp to − 330 bp in the chromatin samples, whereas in the naked DNA the same region appeared strongly digested. This region encompasses the (TTA) 35 region (− 214 to − 318 bp).
To increase the mapping resolution, we primer-extended the DNA of different aliquots from the same samples with the labelled oligonucleotide VEC. The high-resolution results reported in Figure 3(B) shows that the (TTA) 35 repeat was almost completely protected by the nucleosome #1 (from − 349/−324 bp to − 189 bp on multiple positions; indicated by filled arrowheads in Figure 3B ), as shown by comparing the chromatin samples with the naked DNA. In addition MNase-hypersensitive sites (indicated by the empty arrowheads) were localized at the flanking regions of the mapped nucleosome.
Taken together the results reported in Figure 3 demonstrate that the (TTA) 35 repeat is actually organized in a family of positioned nucleosomes covering multiple positions, all sharing the TTA repeat in the middle of the particle.
In vivo chromatin organization of the (TTA) 35 sequence after nucleosome removal
Could the positioned nucleosome on (TTA) 35 be responsible for DNA topoisomerase I failure in generating efficient cleavage sites in vivo? In order to verify this hypothesis we have analysed the in vivo DNA topoisomerase I cleavage activity in a yeast strain lacking both H4 genes and carrying one copy of H4 histone under the control of the GAL1 promoter [14] . This implied that in the presence of glucose as a carbon source, the chromatin organization would be lost and DNA should become accessible in vivo to both MNase and DNA topoisomerase I.
Yeast UKY403 cells, transformed with pFDFG1a, grown in galactose, were divided into two aliquots, washed and resuspended in a growth medium containing galactose or glucose. After 4 h of growth, spheroplasts were treated with different amounts of MNase. The digestion profiles shown in Figure 4 (A) (bulk DNA), indicate that in the galactose-grown cultures the nucleosomal ladder is obtained, whereas in the glucose-grown cultures, a smear appears in the corresponding region of the gel. This suggests that MNase freely accesses DNA when the nucleosomal barriers are absent.
When the samples from galactose-grown or glucose-grown cultures were analysed using an end-labelling technique [18] as in Figure 3 (A), a specific difference was observed ( Figure 4B ). Galactose-grown samples showed protection of the TTA region towards MNase (nucleosome #1), as reported in Figure 3 ; conversely, glucose-grown samples showed a diffuse accessibility to MNase on the (TTA) 35 sequence similar to that of the naked DNA.
DNA topoisomerase I in vivo cleaves the (TTA) 35 sequence after nucleosome removal
The results reported in Figure 4 (B), demonstrate that the chromatin organization of the (TTA) 35 repeat was completely lost when cells were grown in glucose. Since in these conditions MNase accesses the (TTA) 35 repeat with the same efficiency in vivo and in vitro, we wanted to evaluate whether DNA topoisomerase I could also reach this sequence when chromatin was no longer organized. We then analysed the same cells for DNA topoisomerase I cleavage-site induction at high resolution ( Figure 5A ). The samples were primer-extended starting from the labelled oligonucleotide VEC. The reactivity of DNA topoisomerase I in the glucose-grown culture was highly enhanced compared with that observed in the galactose-grown culture. In addition, the cleavage profile of glucose-grown samples (indicated by arrows in Figure 5 ) almost completely overlapped that obtained in vitro (see Figure 1) . We then analysed the same samples in a different chromosomal location (the NTS2 region of the ribosomal DNA) as a control. In fact, we have previously shown [7, 20] that in this nucleosome-free region [22] a strong DNA topoisomerase I cleavage site occurs at − 171 bp from the RIS [7] . Results are shown in Figure 5(B) . When the oligonucleotide r3 [−268 bp from the 35S RIS] was primer-extended, both conditions (glucose-grown and galactose-grown, i.e. nucleosome present/absent respectively) showed the − 171 cleavage site, demonstrating the same reactivity of DNA topoisomerase I in In order to exclude that the observed differences in accessibility to the TTA region were due to different amounts of DNA topoisomerase I in the two growth conditions, we measured both TOP1 mRNA production and DNA-relaxing activity (results not shown). All evaluations showed a slight increase in mRNA and DNA topoisomerase I activity in cells from glucose-grown cultures; however, such a small difference did not justify the strong enhancements observed in the in vivo cleavage profile ( Figure 5A ).
DISCUSSION
It is generally accepted that all sequences in DNA can be substrates for DNA topoisomerase I relaxing activity, even though DNA topoisomerase I seems to have a higher reactivity towards some particular sequences showing structural features such as DNA bending [13, 23] . The high-resolution mapping of in vivo DNA topoisomerase I site-specific activity concerns nucleosomefree regions [5] [6] [7] . In order to verify whether nucleosomes affect DNA topoisomerase I site-specific cleavages, we studied a natural DNA sequence repeating the TTA trinucleotide 35 times. Such a sequence provides the locally bent TA step [12] , presumably a good substrate for local DNA topoisomerase I cleavage induction and an intrinsic flexibility [11] potentially useful to efficiently assemble the nucleosome.
The TTA trinucleotide repeat has proved to be efficiently cleaved in vitro by DNA topoisomerase I (Figure 1 ) in the repeated tract and also in its surrounding regions, confirming the preference of the enzyme for this sequence. Conversely, an in vivo approach showed a reduced reactivity of the same sequence towards DNA topoisomerase I. Thus it is conceivable to hypothesize that chromatin structure affects DNA topoisomerase I cleavage. Recently Roca and co-workers [10] observed that DNA topoisomerase II is more efficient than DNA topoisomerase I in releasing topological stress from nucleosomal substrates; this supports the hypothesis that nucleosomes may represent a barrier for DNA topoisomerase I activity. Because of this a distinction between the global relaxing activity and the local sitespecific cleavage reaction should be taken into consideration. In fact a different chromatin organization in a given substrate may not be a determinant for the whole relaxing activity of DNA topoisomerase I; indeed the enzyme can release torsional stress acting on different sites in the substrate. Conversely, when a given sequence is analysed in terms of cleavage activity exerted by DNA topoisomerase I, the absence/presence of a nucleosome could be very relevant; this latter point was investigated by the experimental system in the present study.
In order to verify this hypothesis, we studied the in vivo chromatin organization of the (TTA) 35 tract. As shown in Figure 3 , a positioned nucleosome occupies the (TTA) 35 region possibly hindering the DNA topoisomerase I cleavage activity. We then employed a yeast strain carrying a plasmid in which the H4 gene is under the control of the GAL1 promoter. This allowed us to switch on/off the synthesis of this histone, depending on the carbon source. In the galactose-grown condition the presence of nucleosomes impairs the DNA topoisomerase I approach to the (TTA) 35 sequence. Conversely, in the glucose-grown condition, when H4 production is repressed, no organized chromatin is observed on the TTA repeat and DNA topoisomerase I increases its sequence-specific activity, particularly on the (TTA) 35 tract ( Figure 4) .
In order to evaluate the cleavage difference of DNA topoisomerase I in vivo, in vitro and when chromatin is destructured (i.e. H4 is no longer synthesized in glucose medium), we quantified the DNA topoisomerase I digestion profiles and the results are compared in Figure 6 . As shown, when chromatin is regularly organized (in vivo and in vivo galactose-grown; see also the chromatin profiles in Figures 3 and 4) approx. 5-6 % of the digested material is represented by the TTA repeat. Conversely the relative digestion of the TTA repeat when samples are reacted in vitro with DNA topoisomerase I reaches values of approx. 30 %. Also the dissolution of regularly organized chromatin allows DNA topoisomerase I to digest the TTA repeat in vivo, but with an efficiency of 15 % (approx. 3-fold higher than on the regular chromatin).
Thus we can conclude that: (i) DNA topoisomerase I efficiently reacts with the TTA repeat; (ii) the (TTA) 35 sequence, the longest and most stable among the simple repeated sequences in S. cerevisiae [24] , is organized in a positioned nucleosome and this can possibly account for its high stability, in fact each nucleosome stores one negative supercoil [25, 26] , thus preventing DNA denaturation and induction of conformational alterations responsible for genetic instability [27] ; and (iii) the positioned nucleosome on the (TTA) 35 sequence represents a hindrance to the DNA topoisomerase I activity. This last conclusion, based on the glucose/galactose experiments, represents the first formal evidence that DNA topoisomerase I cannot react with nucleosomal DNA.
Despite the well-known chemistry concerning the DNA topoisomerase I mechanism of action and the interference with small inhibitors largely employed in chemotherapy, so far no details are known about the possible interference that nucleosomes could represent in vivo towards the topoisomerization reaction. In the present study we provide direct evidence clarifying this task.
